These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31454708)

  • 1. Improving therapy of severe infections through drug repurposing of synergistic combinations.
    Cheng YS; Williamson PR; Zheng W
    Curr Opin Pharmacol; 2019 Oct; 48():92-98. PubMed ID: 31454708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug repurposing screens and synergistic drug-combinations for infectious diseases.
    Zheng W; Sun W; Simeonov A
    Br J Pharmacol; 2018 Jan; 175(2):181-191. PubMed ID: 28685814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Repurposing to Fight Colistin and Carbapenem-Resistant Bacteria.
    Peyclit L; Baron SA; Rolain JM
    Front Cell Infect Microbiol; 2019; 9():193. PubMed ID: 31245302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy: the propitious rationale for drug development.
    Phougat N; Khatri S; Singh A; Dangi M; Kumar M; Dabur R; Chhillar AK
    Comb Chem High Throughput Screen; 2014 Jan; 17(1):53-67. PubMed ID: 24138510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria.
    Liu Y; Tong Z; Shi J; Li R; Upton M; Wang Z
    Theranostics; 2021; 11(10):4910-4928. PubMed ID: 33754035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy.
    Ejim L; Farha MA; Falconer SB; Wildenhain J; Coombes BK; Tyers M; Brown ED; Wright GD
    Nat Chem Biol; 2011 Jun; 7(6):348-50. PubMed ID: 21516114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing Screen Identifies Unconventional Drugs With Activity Against Multidrug Resistant
    Cheng YS; Sun W; Xu M; Shen M; Khraiwesh M; Sciotti RJ; Zheng W
    Front Cell Infect Microbiol; 2018; 8():438. PubMed ID: 30662875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Drug-Repurposing-Driven Advances in the Discovery of Novel Antibiotics.
    Konreddy AK; Rani GU; Lee K; Choi Y
    Curr Med Chem; 2019; 26(28):5363-5388. PubMed ID: 29984648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprogramming of antibiotics to combat antimicrobial resistance.
    Dubey KK; Indu ; Sharma M
    Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000168. PubMed ID: 32776618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repositioning of non-antibiotic drugs as an alternative to microbial resistance: a systematic review.
    Foletto VS; da Rosa TF; Serafin MB; Bottega A; Hörner R
    Int J Antimicrob Agents; 2021 Sep; 58(3):106380. PubMed ID: 34166776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic combinations of anthelmintic salicylanilides oxyclozanide, rafoxanide, and closantel with colistin eradicates multidrug-resistant colistin-resistant Gram-negative bacilli.
    Domalaon R; Okunnu O; Zhanel GG; Schweizer F
    J Antibiot (Tokyo); 2019 Aug; 72(8):605-616. PubMed ID: 31028351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens.
    Thangamani S; Younis W; Seleem MN
    PLoS One; 2015; 10(7):e0133877. PubMed ID: 26222252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination therapy against multidrug-resistant bacteria].
    Araoka H
    Nihon Rinsho; 2012 Feb; 70(2):305-10. PubMed ID: 22413536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradigm Shift in Drug Re-purposing From Phenalenone to Phenaleno-Furanone to Combat Multi-Drug Resistant
    Mujawar S; Gatherer D; Lahiri C
    Front Cell Infect Microbiol; 2018; 8():402. PubMed ID: 30488026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing auranofin for the treatment of cutaneous staphylococcal infections.
    Thangamani S; Mohammad H; Abushahba MF; Sobreira TJ; Seleem MN
    Int J Antimicrob Agents; 2016 Mar; 47(3):195-201. PubMed ID: 26895605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination approaches to combat multidrug-resistant bacteria.
    Worthington RJ; Melander C
    Trends Biotechnol; 2013 Mar; 31(3):177-84. PubMed ID: 23333434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigational drugs for the treatment of infections caused by multidrug-resistant Gram-negative bacteria.
    Avery LM; Nicolau DP
    Expert Opin Investig Drugs; 2018 Apr; 27(4):325-338. PubMed ID: 29611447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
    Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
    Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.